Mark Emalfarb
Founder at DYADIC INTERNATIONAL, INC.
Net worth: 8 M $ as of 2024-03-30
Mark Emalfarb active positions
| Companies | Position | Start | End |
|---|---|---|---|
| DYADIC INTERNATIONAL, INC. | Director/Board Member | 2003-12-31 | - |
| Chief Executive Officer | 2008-05-31 | - | |
| Founder | 1978-12-31 | - | |
| President | 2008-05-31 | - | |
| Chairman | 2008-05-31 | 2014-12-31 | |
Dyadic International (USA), Inc.
 Dyadic International (USA), Inc. BiotechnologyHealth Technology Part of Dyadic International, Inc., Dyadic International (USA), Inc. researches and manufactures genes. The private company is based in Jupiter, FL. The CEO of the company is Mark A. Emalfarb. | Chief Executive Officer | 2011-10-04 | - |
| Chairman | 2011-10-04 | - | |
Biotechnology Development for Industry in Pharmaceuticals SLU
 Biotechnology Development for Industry in Pharmaceuticals SLU Miscellaneous Commercial ServicesCommercial Services Biotechnology Development for Industry in Pharmaceuticals SL provides biotechnology solutions to the health and food sectors. Its products include vaccine in animal health, and human health products. It also offers product development, process development, and contract manufacturing services. The company is headquartered in Boecillo, Spain. | Director/Board Member | 2017-09-12 | - |
Career history of Mark Emalfarb
Training of Mark Emalfarb
| University of Iowa | Undergraduate Degree |
Statistics
International
| United States | 4 |
| Spain | 2 |
Operational
| Director/Board Member | 2 |
| Chief Executive Officer | 2 |
| Chairman | 2 |
Sectoral
| Health Services | 2 |
| Consumer Services | 2 |
| Health Technology | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| DYADIC INTERNATIONAL, INC. | Health Services |
| Private companies | 2 |
|---|---|
Dyadic International (USA), Inc.
Dyadic International (USA), Inc. BiotechnologyHealth Technology Part of Dyadic International, Inc., Dyadic International (USA), Inc. researches and manufactures genes. The private company is based in Jupiter, FL. The CEO of the company is Mark A. Emalfarb. | Health Technology |
Biotechnology Development for Industry in Pharmaceuticals SLU
Biotechnology Development for Industry in Pharmaceuticals SLU Miscellaneous Commercial ServicesCommercial Services Biotechnology Development for Industry in Pharmaceuticals SL provides biotechnology solutions to the health and food sectors. Its products include vaccine in animal health, and human health products. It also offers product development, process development, and contract manufacturing services. The company is headquartered in Boecillo, Spain. | Commercial Services |
- Stock Market
- Insiders
- Mark Emalfarb
- Experience
